Lorenz, Elizabeth C. http://orcid.org/0000-0003-1012-9409
Petterson, Tanya M. http://orcid.org/0000-0003-4075-7334
Zaniletti, Isabella http://orcid.org/0000-0003-1234-3468
Lackore, Kandace A. http://orcid.org/0000-0001-9215-5138
Johnson, Bradley K. http://orcid.org/0000-0002-9005-3434
Mai, Martin L.
Nair, Sumi S.
Bentall, Andrew J. http://orcid.org/0000-0002-8495-9782
Yost, Kathleen J. http://orcid.org/0000-0002-9641-5627
Eton, David T. http://orcid.org/0000-0001-8715-1511
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (DK 123313)
Article History
Received: 27 April 2022
Accepted: 12 August 2022
First Online: 3 September 2022
Declarations
:
: Our study was approved by the Mayo Clinic Institutional Review Board (#19–001693), and oral consent was obtained from participants. All research was performed in accordance with the Declaration of Helsinki. We received a waiver of documentation of informed consent (e.g. oral consent) from the Mayo Clinic Institutional Review Board.
: Not applicable.
: The authors declare that they have no competing interests.